{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:53:11Z","timestamp":1792050791354,"version":"4.4.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background: Inadequate protein intake and hypoalbuminemia, indicators of protein-energy wasting, are among the strongest mortality predictors in hemodialysis patients. Hemodialysis patients are frequently counseled on dietary phosphorus restriction, which may inadvertently lead to decreased protein intake. We hypothesized that, in hypoalbuminemic hemodialysis patients, provision of high-protein meals during hemodialysis combined with a potent phosphorus binder increases serum albumin without raising phosphorus levels.<\/jats:p>\n                  <jats:p>Methods: We conducted a randomized controlled trial in 110 adults undergoing thrice-weekly hemodialysis with serum albumin &amp;lt;4.0 g\/dL recruited between July 2010 and October 2011 from eight Southern California dialysis units. Patients were randomly assigned to receive high-protein (50\u201355 g) meals during dialysis, providing 400\u2013500 mg phosphorus, combined with lanthanum carbonate versus low-protein (&amp;lt;1 g) meals during dialysis, providing &amp;lt;20 mg phosphorus. Prescribed nonlanthanum phosphorus binders were continued over an 8-week period. The primary composite outcome was a rise in serum albumin of \u22650.2 g\/dL while maintaining phosphorus between 3.5\u2013&amp;lt;5.5 mg\/dL. Secondary outcomes included achievement of the primary outcome's individual endpoints and changes in mineral and bone disease and inflammatory markers.<\/jats:p>\n                  <jats:p>Results: Among 106 participants who satisfied the trial entrance criteria, 27% (n = 15) and 12% (n = 6) of patients in the high-protein versus low-protein hemodialysis meal groups, respectively, achieved the primary outcome (intention-to-treat P-value = 0.045). A lower proportion of patients in the high-protein versus low-protein intake groups experienced a meaningful rise in interleukin-6 levels: 9% versus 31%, respectively (P = 0.009). No serious adverse events were observed.<\/jats:p>\n                  <jats:p>Conclusion: In hypoalbuminemic hemodialysis patients, high-protein meals during dialysis combined with lanthanum carbonate are safe and increase serum albumin while controlling phosphorus.<\/jats:p>","DOI":"10.1093\/ndt\/gfw323","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T20:39:28Z","timestamp":1474576768000},"page":"1233-1243","source":"Crossref","is-referenced-by-count":10,"title":["Effect of high-protein meals during hemodialysis combined with lanthanum carbonate in hypoalbuminemic dialysis patients: findings from the FrEDI randomized controlled trial"],"prefix":"10.1093","volume":"32","author":[{"given":"Connie M.","family":"Rhee","sequence":"first","affiliation":[{"name":"1Harold Simmons Center for Chronic Disease Research and Epidemiology, University of California Irvine School of Medicine, Orange, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"You","sequence":"additional","affiliation":[{"name":"1Harold Simmons Center for Chronic Disease Research and Epidemiology, University of California Irvine School of Medicine, Orange, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Koontz Parsons","sequence":"additional","affiliation":[{"name":"2Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R.","family":"Tortorici","sequence":"additional","affiliation":[{"name":"1Harold Simmons Center for Chronic Disease Research and Epidemiology, University of California Irvine School of Medicine, Orange, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Bross","sequence":"additional","affiliation":[{"name":"2Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"St-Jules","sequence":"additional","affiliation":[{"name":"3Center for Healthful Behavior Change, New York University School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Jing","sequence":"additional","affiliation":[{"name":"1Harold Simmons Center for Chronic Disease Research and Epidemiology, University of California Irvine School of Medicine, Orange, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Lee","sequence":"additional","affiliation":[{"name":"4UCLA Fielding School of Public Health, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Benner","sequence":"additional","affiliation":[{"name":"5DaVita Inc., El Segundo, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba P.","family":"Kovesdy","sequence":"additional","affiliation":[{"name":"6Division of Nephrology, University of Tennessee Health Science Center, Memphis, TN, USA"},{"name":"7Nephrology Section, Memphis Veterans Affairs Medical Center, Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Mehrotra","sequence":"additional","affiliation":[{"name":"8Kidney Research Institute and Harborview Medical Center, Division of Nephrology, University of Washington, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel D.","family":"Kopple","sequence":"additional","affiliation":[{"name":"4UCLA Fielding School of Public Health, Los Angeles, CA, USA"},{"name":"9Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, USA"},{"name":"10David Geffen School of Medicine at UCLA, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[{"name":"1Harold Simmons Center for Chronic Disease Research and Epidemiology, University of California Irvine School of Medicine, Orange, CA, USA"},{"name":"2Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, USA"},{"name":"4UCLA Fielding School of Public Health, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,9,22]]},"reference":[{"key":"2025102312501206100_GFW323C1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1525-139X.2012.01097.x","article-title":"Accuracy and limitations of the diagnosis of malnutrition in dialysis patients","volume":"25","author":"Kovesdy","year":"2012","journal-title":"Semin Dial"},{"issue":"(6 Suppl 2)","key":"2025102312501206100_GFW323C2","first-page":"S1","article-title":"Clinical practice guidelines for nutrition in chronic renal failure. K\/DOQI, National Kidney Foundation","volume":"35","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"2025102312501206100_GFW323C3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1053\/ajkd.2002.35679","article-title":"Association of serum albumin and atherosclerosis in chronic hemodialysis patients","volume":"40","author":"Beddhu","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2025102312501206100_GFW323C4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/j.ajkd.2008.07.031","article-title":"Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access","volume":"53","author":"Lacson","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2025102312501206100_GFW323C5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/j.ajkd.2006.03.049","article-title":"Longitudinal associations between dietary protein intake and survival in hemodialysis patients","volume":"48","author":"Shinaberger","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2025102312501206100_GFW323C6","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2025102312501206100_GFW323C7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ndt\/gfs404","article-title":"Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?","volume":"28","author":"Fouque","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312501206100_GFW323C8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"2025102312501206100_GFW323C9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ndt\/gfi270","article-title":"Calcification and the usual suspect phosphate: still guilty but there are other guys behind the scenes","volume":"21","author":"Ketteler","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312501206100_GFW323C10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10157-005-0385-4","article-title":"Pathogenesis of vascular calcification in dialysis patients","volume":"9","author":"Ketteler","year":"2005","journal-title":"Clin Exp Nephrol"},{"key":"2025102312501206100_GFW323C11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000221064","article-title":"Risk factors for cardiovascular calcifications in non-diabetic Caucasian haemodialysis patients","volume":"32","author":"Schlieper","year":"2009","journal-title":"Kidney Blood Press Res"},{"key":"2025102312501206100_GFW323C12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.ajkd.2014.01.429","article-title":"Balancing nutrition and serum phosphorus in maintenance dialysis","volume":"64","author":"Fouque","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2025102312501206100_GFW323C13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.jrn.2012.11.001","article-title":"Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients","volume":"23","author":"Kalantar-Zadeh","year":"2013","journal-title":"J Ren Nutr"},{"key":"2025102312501206100_GFW323C14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1051-2276(03)00069-4","article-title":"Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross-sectional results from the HEMO study","volume":"13","author":"Burrowes","year":"2003","journal-title":"J Ren Nutr"},{"key":"2025102312501206100_GFW323C15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrneph.2011.60","article-title":"Diets and enteral supplements for improving outcomes in chronic kidney disease","volume":"7","author":"Kalantar-Zadeh","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"2025102312501206100_GFW323C16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/sdi.12348","article-title":"Dietary restrictions in dialysis patients: is there anything left to eat?","volume":"28","author":"Kalantar-Zadeh","year":"2015","journal-title":"Semin Dial"},{"key":"2025102312501206100_GFW323C17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1525-139X.2011.00849.x","article-title":"The phosphate binder equivalent dose","volume":"24","author":"Daugirdas","year":"2011","journal-title":"Semin Dial"},{"key":"2025102312501206100_GFW323C18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2009.96","article-title":"Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial","volume":"301","author":"Sullivan","year":"2009","journal-title":"JAMA"},{"key":"2025102312501206100_GFW323C19","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/ndt\/gfh941","article-title":"Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction","volume":"20","author":"Kalantar-Zadeh","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2025102312501206100_GFW323C20","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2215\/CJN.02760608","article-title":"OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients","volume":"3","author":"Kopple","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312501206100_GFW323C21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/j.jrn.2007.08.009","article-title":"Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs","volume":"17","author":"Lacson","year":"2007","journal-title":"J Ren Nutr"},{"key":"2025102312501206100_GFW323C22","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin Chem"},{"key":"2025102312501206100_GFW323C23","doi-asserted-by":"crossref","first-page":"c337","DOI":"10.1159\/000237143","article-title":"The randomized controlled trial","volume":"113","author":"Stel","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"2025102312501206100_GFW323C24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199309303291404","article-title":"The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis","volume":"329","author":"Owen","year":"1993","journal-title":"N Engl J Med"},{"key":"2025102312501206100_GFW323C25","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3945\/ajcn.2008.26665","article-title":"Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?","volume":"88","author":"Shinaberger","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"2025102312501206100_GFW323C26","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1681\/ASN.2006040413","article-title":"Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status","volume":"17","author":"Pupim","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2025102312501206100_GFW323C27","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1046\/j.1523-1755.2002.00530.x","article-title":"Therapeutic effects of oral nutritional supplementation during hemodialysis","volume":"62","author":"Caglar","year":"2002","journal-title":"Kidney Int"},{"key":"2025102312501206100_GFW323C28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13539-013-0115-9","article-title":"Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial","volume":"4","author":"Rattanasompattikul","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025102312501206100_GFW323C29","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.ki.5002503","article-title":"Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate","volume":"72","author":"Aime","year":"2007","journal-title":"Kidney Int"},{"key":"2025102312501206100_GFW323C30","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1111\/j.1523-1755.2005.00753.x","article-title":"Progressive accumulation of lanthanum in the liver of normal and uremic rats","volume":"68","author":"Slatopolsky","year":"2005","journal-title":"Kidney Int"},{"key":"2025102312501206100_GFW323C31","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2215\/CJN.04451206","article-title":"Serum and dialysate potassium concentrations and survival in hemodialysis patients","volume":"2","author":"Kovesdy","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102312501206100_GFW323C32","doi-asserted-by":"crossref","first-page":"R801","DOI":"10.1152\/ajpregu.00715.2003","article-title":"Effects of protein malnutrition on IL-6-mediated signaling in the liver and the systemic acute-phase response in rats","volume":"287","author":"Ling","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"(Suppl 3)","key":"2025102312501206100_GFW323C33","first-page":"S16","article-title":"Regular dialysis treatment in Germany: the role of non-profit organisations","volume":"13","author":"Wizemann","year":"2000","journal-title":"J Nephrol"},{"key":"2025102312501206100_GFW323C34","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/j.1523-1755.2000.00385.x","article-title":"Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients","volume":"58","author":"Leavey","year":"2000","journal-title":"Kidney Int"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/32\/7\/1233\/18110366\/gfw323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/32\/7\/1233\/18110366\/gfw323.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:51:22Z","timestamp":1761238282000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/32\/7\/1233\/3059464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,22]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,9,22]]},"published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfw323","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7]]},"published":{"date-parts":[[2016,9,22]]}}}